Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 10 of the 13 calendar months from Oct 2025 to Oct 2026: Nov 2025, Dec 2025, Jan 2026, Feb 2026, Mar 2026, Apr 2026, May 2026, Jun 2026, Aug 2026 and Sep 2026.
- Largest single sale: $2.1M (28,311 shares) of BridgeBio Pharma, Inc. on Dec 15, 2025. Filing
- Last sale before this period: Oct 9, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | Chief Executive Officer, Director | Jun 27, 2019 | Sep 21, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Sep 17, 2026, BridgeBio Pharma, Inc.: sold 10,000 shares for $691K, under a disclosed plan (some held indirectly). 1 filing: 1
- Aug 19, 2026, BridgeBio Pharma, Inc.: sold 10,000 shares for $840K, under a disclosed plan (some held indirectly). 1 filing: 1
- Aug 18, 2026, BridgeBio Pharma, Inc.: sold 34,980 shares for $2.9M, under a disclosed plan. 1 filing: 1
- Aug 16, 2026, BridgeBio Pharma, Inc.: 71,217 shares vested; 36,237 shares withheld by the company for taxes. 1 filing: 1
- Jun 5, 2026, BridgeBio Pharma, Inc.: sold 40,000 shares for $2.7M, under a disclosed plan (some held indirectly). 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.